Targeting the glutamine-arginine-proline metabolism axis in cancer-Reference-Cited by-同舟云学术

Targeting the glutamine-arginine-proline metabolism axis in cancer

Published:2024-07-25 Issue:1 Volume:39 Page:
ISSN:1475-6366
Container-title:Journal of Enzyme Inhibition and Medicinal Chemistry
language:en
Short-container-title:Journal of Enzyme Inhibition and Medicinal Chemistry

Author:

Wang Di¹²³,Duan Jiang-jie¹²³⁴,Guo Yu-feng¹,Chen Jun-jie¹²³,Chen Tian-qing⁵,Wang Jun¹²³⁴,Yu Shi-cang¹²³⁴

Affiliation:

1. Department of Stem Cell and Regenerative Medicine, Institute of Pathology and Southwest Cancer Center, Southwest Hospital, Third Military Medical University (Army Medical University), Chongqing, China

2. International Joint Research Center for Precision Biotherapy, Ministry of Science and Technology, Chongqing, China

3. Key Laboratory of Cancer Immunopathology, Ministry of Education, Chongqing, China

4. Jin-feng Laboratory, Chongqing, China

5. School of Pharmacy, Shanxi Medical University, Taiyuan, China

Funder

National Key Research and Development Program of China

National Natural Science Foundation of China

Chongqing Technology Innovation and Application Development Program

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.1080/14756366.2024.2367129

Reference133 articles.

1. The hallmarks of cancer metabolism: still emerging;Pavlova NN;Cell Metab,2022

2. Targeting glutamine metabolism as a therapeutic strategy for cancer;Jin J;Exp Mol Med,2023

3. A shift in glutamine nitrogen metabolism contributes to the malignant progression of cancer;Kodama M;Nat Commun,2020

4. Targeting glutamine metabolism for cancer treatment;Choi YK;Biomol Ther,2018

5. Apoptotic effects of high-dose rapamycin occur in s-phase of the cell cycle;Saqcena M;Cell Cycle,2015